Suppr超能文献

收集孟加拉国、加纳、肯尼亚、莫桑比克和尼泊尔孕产妇免疫接种准备情况的信息:应用世界卫生组织清单。

Gathering information on maternal immunization readiness in Bangladesh, Ghana, Kenya, Mozambique, and Nepal: Applying a WHO checklist.

作者信息

Baral Ranju, Knudson Sophia, Barros Iracema, Cofie Patience, Dapaah Patience, Khan Sadaf, Kumar Sandeep, Mehedi Kamran, Newhouse Lauren, Otiang Elkanah, Owusu Rosemond, Pecenka Clint, Picolo Melanie, Pinto Judite, Quelhas Diana, Routray Satyabrata, Uranw Surendra, Fleming Jessica A

机构信息

Center for Vaccine Innovation and Access, PATH, Seattle, USA.

Primary Health Care, PATH, Seattle, USA.

出版信息

Hum Vaccin Immunother. 2024 Dec 31;20(1):2437258. doi: 10.1080/21645515.2024.2437258. Epub 2024 Dec 17.

Abstract

New respiratory syncytial virus (RSV) maternal vaccines have begun roll out in some countries, with efforts in progress to broaden access worldwide and shorten the timeline to access for low- and middle-income countries (LMICs). Prior to new maternal immunization (MI) introductions, countries will need to evaluate their capacity and readiness for successful introduction. The World Health Organization's Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) project (2016-2019) developed a checklist for countries to self-evaluate their capacity to introduce new maternal vaccines. Here, we report on our use of the MIACSA checklist in Bangladesh, Ghana, Kenya, Mozambique, and Nepal to gather country stakeholders' perceptions of MI readiness and provide additional considerations for implementers when using the checklist to optimize its usefulness.

摘要

新型呼吸道合胞病毒(RSV)孕产妇疫苗已在一些国家开始推广,目前正在努力扩大全球可及性,并缩短低收入和中等收入国家(LMICs)的获取时间线。在引入新的孕产妇免疫(MI)措施之前,各国需要评估其成功引入的能力和准备情况。世界卫生组织的孕产妇免疫和产前保健情况分析(MIACSA)项目(2016 - 2019年)为各国制定了一份自我评估引入新型孕产妇疫苗能力的清单。在此,我们报告我们在孟加拉国、加纳、肯尼亚、莫桑比克和尼泊尔使用MIACSA清单的情况,以收集各国利益相关者对孕产妇免疫准备情况的看法,并为实施者在使用该清单以优化其效用时提供更多考虑因素。

相似文献

3
Facility Readiness Assessment for Maternal Immunization: Results of Field Testing in Kenya and Bangladesh.
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S101-S104. doi: 10.1097/INF.0000000000004608. Epub 2025 Feb 14.
9
Maternal immunization country readiness: a checklist approach.母体免疫接种国家准备情况:清单方法。
Hum Vaccin Immunother. 2020 Dec 1;16(12):3177-3183. doi: 10.1080/21645515.2020.1750248. Epub 2020 May 27.

本文引用的文献

5
Maternal RSV vaccine development. Where to from here?母亲 RSV 疫苗的研发。接下来该怎么做?
Hum Vaccin Immunother. 2021 Nov 2;17(11):4542-4548. doi: 10.1080/21645515.2021.1955608. Epub 2021 Sep 9.
6
Maternal immunization country readiness: a checklist approach.母体免疫接种国家准备情况:清单方法。
Hum Vaccin Immunother. 2020 Dec 1;16(12):3177-3183. doi: 10.1080/21645515.2020.1750248. Epub 2020 May 27.
7
A Vaccine Against Group B : Recent Advances.一种针对B族的疫苗:最新进展
Infect Drug Resist. 2020 Apr 29;13:1263-1272. doi: 10.2147/IDR.S203454. eCollection 2020.
8
Maternal immunisation: collaborating with mother nature.母亲免疫接种:与大自然合作。
Lancet Infect Dis. 2017 Jul;17(7):e197-e208. doi: 10.1016/S1473-3099(17)30229-3. Epub 2017 Apr 19.
10
Immunization of pregnant women: Future of early infant protection.孕妇免疫接种:早期婴儿保护的未来。
Hum Vaccin Immunother. 2015;11(11):2549-55. doi: 10.1080/21645515.2015.1070984. Epub 2015 Sep 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验